MoneyWorks4Me

Bharat Parenterals - Quaterly Results

13 Feb 2024 Evaluate
The revenue for the December 2023 quarter is pegged at Rs. 588.00 millions against Rs. 590.20 millions recorded during the year-ago period.Net Profit recorded in the quarter ended December 2023 rise to 33.07% to Rs. 50.70  millions  compared to R. 38.10 millions in corresponding previous quarter.Operating profit surged to 91.80 millions from the corresponding previous quarter of 74.50 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 588.00 590.20 -0.37 1885.20 1670.10 12.88 2179.80 2120.10 2.82
Other Income 24.00 39.50 -39.24 87.10 118.80 -26.68 188.40 77.80 142.16
PBIDT 91.80 74.50 23.22 334.10 266.50 25.37 402.10 360.00 11.69
Interest 6.10 7.90 -22.78 21.00 13.80 52.17 21.90 9.70 125.77
PBDT 85.70 66.60 28.68 313.10 252.70 23.90 380.20 350.30 8.54
Depreciation 16.70 14.30 16.78 47.90 44.20 8.37 58.50 66.60 -12.16
PBT 69.00 52.30 31.93 265.20 208.50 27.19 321.70 283.70 13.39
TAX 18.30 14.20 28.87 70.00 58.00 20.69 78.30 70.70 10.75
Deferred Tax -3.90 0.70 -657.14 -0.60 1.60 -137.50 -5.70 -9.40 -39.36
PAT 50.70 38.10 33.07 195.20 150.50 29.70 243.40 213.00 14.27
Equity 57.75 57.75 0.00 58.20 57.75 0.78 57.70 57.70 0.00
PBIDTM(%) 15.61 12.62 23.68 17.72 15.96 11.06 18.45 16.98 8.64
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..